What is the recommended dose of midazolam (Benzodiazepine) drip for status epilepticus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midazolam Infusion Dosing for Status Epilepticus

For refractory status epilepticus, administer an IV loading dose of 0.15-0.20 mg/kg of midazolam, followed by a continuous infusion starting at 1 mcg/kg/min (0.06 mg/kg/hr), increasing by 1 mcg/kg/min increments every 15 minutes until seizures stop, up to a maximum of 5 mcg/kg/min (0.3 mg/kg/hr). 1

Loading Dose Protocol

  • Administer 0.15-0.20 mg/kg IV as a bolus when status epilepticus is refractory to standard first-line benzodiazepines (lorazepam or diazepam) 2, 1
  • If additional boluses are needed before starting the infusion, give 0.1-0.3 mg/kg increments up to a cumulative dose of 0.6 mg/kg 3
  • 90% of patients who respond to bolus therapy do so with cumulative doses ≤0.3 mg/kg 3

Continuous Infusion Titration

  • Start infusion at 1 mcg/kg/min (0.06 mg/kg/hr) immediately after the loading dose 2, 1
  • Increase by 1 mcg/kg/min every 15 minutes if seizures persist 2, 1
  • Maximum infusion rate: 5 mcg/kg/min (0.3 mg/kg/hr) 2, 1
  • Continue infusion for 24 hours after seizure cessation before attempting to wean 1

Adjusting Ongoing Infusions

If a patient is already receiving midazolam and experiences breakthrough seizures:

  • Give a bolus equal to or double the hourly infusion dose 1
  • Order bolus doses every 5 minutes as needed for ongoing seizures 1
  • If two boluses are required within one hour, double the infusion rate 1

Alternative Route When IV Access Unavailable

  • IM midazolam: 0.2 mg/kg (maximum 6 mg per dose) 2
  • May repeat every 10-15 minutes if needed 2
  • In adults, 15 mg IM has shown 84% efficacy (36/43 episodes controlled) 4

Critical Safety Considerations

Respiratory Monitoring

  • Prepare for respiratory support before administration regardless of route 2, 1
  • Increased apnea risk when combined with other sedatives 2, 1
  • Continuous oxygen saturation monitoring is mandatory 2, 1
  • In one pediatric study, only 1 of 34 patients required supplemental oxygen and bag-valve-mask ventilation 3

Timing is Critical

  • Effectiveness decreases significantly when initiated >3 hours after seizure onset 5
  • Early administration (within 1 minute of bolus) achieved 88% seizure cessation in prospective studies 3
  • In a multicenter retrospective study, overall efficacy was 64.5%, but notably lower with delayed treatment 5

Common Pitfalls to Avoid

  • Do NOT use flumazenil to reverse respiratory depression unless life-threatening, as it will precipitate seizure recurrence 2, 1
  • Do NOT delay treatment waiting for EEG confirmation—clinical cessation of motor symptoms is sufficient to assess response 3
  • Do NOT forget to address underlying causes (hypoglycemia, hyponatremia, hypoxia, CNS infection) concurrently 1
  • Do NOT use doses lower than 0.15 mg/kg for the loading dose—lower doses are ineffective for refractory status epilepticus 2

Pharmacokinetic Considerations

  • Elimination half-life is approximately 1 hour in children 3
  • Clearance is notably higher in infants (2010 mL/h/kg in a 10-month-old vs. 423-1220 mL/h/kg in older children), which may require higher maintenance doses 3
  • Mean effective infusion rate in pediatric studies was 0.22 mg/kg/hr (approximately 3.7 mcg/kg/min) 6

References

Guideline

Midazolam Infusion for Status Epilepticus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.